Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

High-throughput RNA isoform sequencing using programmable cDNA concatenation

View ORCID ProfileAziz M. Al’Khafaji, View ORCID ProfileJonathan T. Smith, View ORCID ProfileKiran V Garimella, Mehrtash Babadi, View ORCID ProfileMoshe Sade-Feldman, Michael Gatzen, Siranush Sarkizova, View ORCID ProfileMarc A. Schwartz, Victoria Popic, Emily M. Blaum, Allyson Day, Maura Costello, Tera Bowers, Stacey Gabriel, Eric Banks, Anthony A. Philippakis, Genevieve M. Boland, View ORCID ProfilePaul C. Blainey, Nir Hacohen
doi: https://doi.org/10.1101/2021.10.01.462818
Aziz M. Al’Khafaji
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aziz M. Al’Khafaji
  • For correspondence: aalkhafa@broadinstitute.org kiran@broadinstitute.org mehrtash@broadinstitute.org pblainey@broadinstitute.org nhacohen@broadinstitute.org
Jonathan T. Smith
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan T. Smith
Kiran V Garimella
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kiran V Garimella
  • For correspondence: aalkhafa@broadinstitute.org kiran@broadinstitute.org mehrtash@broadinstitute.org pblainey@broadinstitute.org nhacohen@broadinstitute.org
Mehrtash Babadi
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aalkhafa@broadinstitute.org kiran@broadinstitute.org mehrtash@broadinstitute.org pblainey@broadinstitute.org nhacohen@broadinstitute.org
Moshe Sade-Feldman
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
2Department of Medicine, Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Moshe Sade-Feldman
Michael Gatzen
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siranush Sarkizova
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc A. Schwartz
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
3Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
4Division of Hematology/Oncology, Boston Children’s Hospital, Boston, Massachusetts, USA
5Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc A. Schwartz
Victoria Popic
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily M. Blaum
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
2Department of Medicine, Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allyson Day
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maura Costello
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tera Bowers
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Gabriel
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Banks
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony A. Philippakis
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Genevieve M. Boland
6Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul C. Blainey
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
7Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA
8Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul C. Blainey
  • For correspondence: aalkhafa@broadinstitute.org kiran@broadinstitute.org mehrtash@broadinstitute.org pblainey@broadinstitute.org nhacohen@broadinstitute.org
Nir Hacohen
1Broad Institute of Harvard and MIT, Cambridge, MA, USA
9Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
10Harvard Medical School, Boston, MA, USA
11Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aalkhafa@broadinstitute.org kiran@broadinstitute.org mehrtash@broadinstitute.org pblainey@broadinstitute.org nhacohen@broadinstitute.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Alternative splicing is a core biological process that enables profound and essential diversification of gene function. Short-read RNA sequencing approaches fail to resolve RNA isoforms and therefore primarily enable gene expression measurements - an isoform unaware representation of the transcriptome. Conversely, full-length RNA sequencing using long-read technologies are able to capture complete transcript isoforms, but their utility is deeply constrained due to throughput limitations. Here, we introduce MAS-ISO-seq, a technique for programmably concatenating cDNAs into single molecules optimal for long-read sequencing, boosting the throughput >15 fold to nearly 40 million cDNA reads per run on the Sequel IIe sequencer. We validated unambiguous isoform assignment with MAS-ISO-seq using a synthetic RNA isoform library and applied this approach to single-cell RNA sequencing of tumor-infiltrating T cells. Results demonstrated a >30 fold boosted discovery of differentially spliced genes and robust cell clustering, as well as canonical PTPRC splicing patterns across T cell subpopulations and the concerted expression of the associated hnRNPLL splicing factor. Methods such as MAS-ISO-seq will drive discovery of novel isoforms and the transition from gene expression to transcript isoform expression analyses.

Competing Interest Statement

A.M.A., K.V.G., J.S., M.B., P.B., and N.H. have filed a patent on the MAS-seq method. A.A.P. is a Venture Partner and Employee of GV. He has received funding from Verily, Microsoft, Illumina, Bayer, Pfizer, Biogen, Abbvie, Intel, and IBM. M.S.F. receives funding from Bristol-Myers Squibb. G.M.B. has served on SAB and on the steering committee for Nektar Therapeutics. She has SRAs with Olink proteomics and Palleon Pharmaceuticals. She served on SAB and as a speaker for Novartis N.H. holds equity in BioNTech and is a founder and equity holder of Danger Bio. P.C.B. is a consultant to and/or holds equity in companies that develop or apply genomic or genome editing technologies: 10X Genomics, General Automation Lab Technologies, Celsius Therapeutics, Next Gen Diagnostics LLC, Cache DNA, and Concerto Biosciences. P.C.B. receives funding from industry for unrelated work.

Footnotes

  • https://github.com/broadinstitute/mas-seq-paper-data

  • https://github.com/broadinstitute/longbow

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High-throughput RNA isoform sequencing using programmable cDNA concatenation
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High-throughput RNA isoform sequencing using programmable cDNA concatenation
Aziz M. Al’Khafaji, Jonathan T. Smith, Kiran V Garimella, Mehrtash Babadi, Moshe Sade-Feldman, Michael Gatzen, Siranush Sarkizova, Marc A. Schwartz, Victoria Popic, Emily M. Blaum, Allyson Day, Maura Costello, Tera Bowers, Stacey Gabriel, Eric Banks, Anthony A. Philippakis, Genevieve M. Boland, Paul C. Blainey, Nir Hacohen
bioRxiv 2021.10.01.462818; doi: https://doi.org/10.1101/2021.10.01.462818
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
High-throughput RNA isoform sequencing using programmable cDNA concatenation
Aziz M. Al’Khafaji, Jonathan T. Smith, Kiran V Garimella, Mehrtash Babadi, Moshe Sade-Feldman, Michael Gatzen, Siranush Sarkizova, Marc A. Schwartz, Victoria Popic, Emily M. Blaum, Allyson Day, Maura Costello, Tera Bowers, Stacey Gabriel, Eric Banks, Anthony A. Philippakis, Genevieve M. Boland, Paul C. Blainey, Nir Hacohen
bioRxiv 2021.10.01.462818; doi: https://doi.org/10.1101/2021.10.01.462818

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetics
Subject Areas
All Articles
  • Animal Behavior and Cognition (4382)
  • Biochemistry (9591)
  • Bioengineering (7090)
  • Bioinformatics (24858)
  • Biophysics (12610)
  • Cancer Biology (9956)
  • Cell Biology (14350)
  • Clinical Trials (138)
  • Developmental Biology (7948)
  • Ecology (12105)
  • Epidemiology (2067)
  • Evolutionary Biology (15988)
  • Genetics (10925)
  • Genomics (14738)
  • Immunology (9869)
  • Microbiology (23660)
  • Molecular Biology (9484)
  • Neuroscience (50860)
  • Paleontology (369)
  • Pathology (1539)
  • Pharmacology and Toxicology (2682)
  • Physiology (4013)
  • Plant Biology (8657)
  • Scientific Communication and Education (1508)
  • Synthetic Biology (2394)
  • Systems Biology (6433)
  • Zoology (1346)